![Sandra Aung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sandra Aung
Director Técnico/Científico/I+D en
AMBRX INC
.
Perfil
Sandra Aung is currently Chief Clinical Officer at Ambrx, Inc. since 2023.
Formerly, Dr. Aung was Chief Clinical Development Officer & Senior VP at OncoSec Medical, Inc. from 2020 to 2023.
Dr. Aung earned a doctorate from Vanderbilt University.
Cargos activos de Sandra Aung
| Empresas | Cargo | Inicio |
|---|---|---|
| AMBRX INC | Director Técnico/Científico/I+D | 01/02/2023 |
Antiguos cargos conocidos de Sandra Aung.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Corporate Officer/Principal | 01/01/2023 |
Formación de Sandra Aung.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
5
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
- Bolsa de valores
- Insiders
- Sandra Aung
